CCO Infectious Disease Podcast

Advancements in Viral Hepatitis From EASL 2022

Episode Summary

Listen to expert insights from Nancy Reau, MD, on updates and new viral hepatitis data from EASL 2022, including HBV novel therapeutics in development, therapeutic vaccination for HBV, emerging treatments for HDV, HCV care cascade, and the need for HCC monitoring post HCV cure.

Episode Notes

In this episode, Nancy Reau, MD, discusses new viral hepatitis data from EASL 2022, including:

• Novel therapeutics for HBV
• Therapeutic vaccination for HBV
• Emerging treatment options for HDV
• HCV care cascade
• HCC monitoring after HCV cure

Presenter: 

Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Follow along with the downloadable slideset at: 
https://bit.ly/3yJAruD

Link to full program:
https://bit.ly/3IeUapm